Fill & finish, packaging

SP Scientific partners with i-Dositecno, integrates its fill-finish offering

26-Aug-2019 By Vassia Barba

SP Scientific partners with Spanish i-Dositecno to offer complete aseptic vial and syringe fill-finish lines to clients in Europe and North America.

Wasdell acquisition to support outsourced supply chain in Europe

20-May-2019 By Maggie Lynch

Wasdell Group has acquired specialist manufacturer and packager, Honeywood Limited in an aim to build its manufacturing and packaging capacity in the UK to support European supply chain.

MHRA approves Sharp’s clinical services center in Wales

16-Apr-2019 By Maggie Lynch

Sharp’s clinical services center is approved by the MHRA and now ready to offer services for serialization and trial management while reducing carbon footprint with the addition of solar panel systems.

2018 regulatory round-up: Patient safety, data transparency, innovative trial designs

18-Dec-2018 By Melissa Fassbender

Global regulatory agencies had a busy 2018. Here, we take a look back at some of the key developments throughout the year, as the industry navigated challenging politics, pressure to increase transparency, and the rapidly evolving digital health space.

Catalent expands biologics facility, to create 36 new jobs

04-Dec-2018 By Maggie Lynch

Catalent is expanding its US biologics packaging facility, following recent investments and expansions in the Asia-Pacific region.

Catalent’s China expansion to meet growing clinical trial industry

29-Nov-2018 By Maggie Lynch

Catalent’s existing clinical packaging facility in Shanghai is nearing the end of its expansion, ready to meet the needs of the growing Asia-Pacific region.

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

30-Oct-2018 By Melissa Fassbender

AAPS PharmSci 360 is a new conference this year, created in response to a desire for “fresh science,” specifically with chemical and biomolecular components. So what can you expect?

US FDA says compounder used non-sterile wipes during sterile drug production

08-Oct-2018 By Flora Southey

The US FDA has issued a warning letter to a compounding pharmacy in California, US, after a facility inspection revealed FDCA violations.

New provider on the block: Experic marks launch with plans to build cGMP facility targeting small to mid-sized customers

03-Oct-2018 By Melissa Fassbender

The pharmaceutical supply services provider Experic has marked its official launch with plans to construct its headquarters at a newly leased Class A research, manufacturing, and packaging facility.

Ajinomoto Althea opens new manufacturing facility in San Diego

28-Aug-2018 By Maggie Lynch

Ajinomoto Althea’s new ADC and highly potent fill and finish facility in San Diego supports early clinical phase through commercially approved programs.

Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial

22-Aug-2018 By Ben Hargreaves

The Canadian CDMO Dalton Pharma Services will manufacture Arch Biopartners' drug candidate for use in Phase I clinical trials.

Life science advances and gender equity on the program for DIA 2018

19-Jun-2018 By Melissa Fassbender

This year’s DIA Global Annual Meeting will focus on the latest global trends and showcase the "diverse group of key individuals driving the life science ecosystem forward," says DIA Americas managing director.

State of the Industry

State of the Industry: Taking the pulse of the contract services market

11-Jun-2018 By Melissa Fassbender

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.

Emergent initiates $50m expansion, expects to hire 60

07-Jun-2018 By Melissa Fassbender

Emergent BioSolutions has initiated a $50m multi-year expansion at the company’s Baltimore, MD-based fill/finish facility.

Chinese gov't outlines changes to import tariff, clinical trial applications, IP protection

07-May-2018 By Melissa Fassbender

Significant regulatory changes by the Chinese government will accelerate drug development timelines and positively affect sponsors’ bottom line, says CRO.